United States · FDA National Drug Code directory
Metaxalone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69306-100_cd0929e3-c3b2-c89a-e053-2a95a90a7b2a
- Product NDC
- 69306-100
- Form
- TABLET
- Composition / generic term
- Metaxalone
- Labeler
- Doc Rx
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190401
- Source listing expiry
- 20261231
Source-listed ingredients
- METAXALONE — 800 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (69306-100-01) · 69306-100-01
- 20 TABLET in 1 BOTTLE (69306-100-02) · 69306-100-02
- 30 TABLET in 1 BOTTLE (69306-100-03) · 69306-100-03
- 60 TABLET in 1 BOTTLE (69306-100-06) · 69306-100-06
- 90 TABLET in 1 BOTTLE (69306-100-09) · 69306-100-09
- 15 TABLET in 1 BOTTLE (69306-100-15) · 69306-100-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →